Home › NDC Lookup › Ingredients › Atorvastatin Calcium › 71335-3179-01
⚪image loading
(from DailyMed)

Atorvastatin Calcium 80 mg Tablet, Film Coated, 30-count — NDC 71335-3179-1 (Billing 71335-3179-01)

by Bryant Ranch Prepack · 30 TABLET, FILM COATED in 1 BOTTLE

This is a package of 30 tablets of Atorvastatin Calcium 80 mg Tablet, Film Coated from Bryant Ranch Prepack, marketed since Feb 2024 and currently FDA-listed. It is the main listing for this product, which comes in 4 package sizes.

NDC 71335-3179-01
🏷️ FDA NDC (as labeled) 71335-3179-1 billing pads the package segment with a zero
This package
Contains30-count Pack sizes4 compare ↓
Main listing for product 71335-3179 · Also comes in: 60 tablets 71335-3179-2 90 tablets 71335-3179-3 180 tablets 71335-3179-4
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 71335-3179-1 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
71335 labeler · 3179 product · 1 package
Package marketed since
Sep 8, 2026
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 7133531791 1
FDA record last changed
Oct 8, 2026
⚠️
Other active recalls for Atorvastatin Calcium (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0020-2026
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0019-2026
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0017-2026
Class II · Sep 19, 2025 — Failed Dissolution Specifications (Ascend Laboratories, LLC) · FDA recall D-0018-2026
Class II · Mar 17, 2025 — Failed dissolution specifications: lower than specifications (BIOCON PHARMA INC) · FDA recall D-0306-2025
Class II · Mar 16, 2023 — CGMP Deviations (Northwind Pharmaceuticals LLC) · FDA recall D-0548-2023
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 71335-3179-1
Product NDC 71335-3179
11-digit billing NDC 71335317901
Application # ANDA217118
SPL Set ID 4c68ba68-378b-4e23-b8da-9af11d4963a2
Established class (EPC) HMG-CoA Reductase Inhibitor
Mechanism of action Hydroxymethylglutaryl-CoA Reductase Inhibitors
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-02-13
Route ORAL
Dosage form TABLET, FILM COATED
Substance ATORVASTATIN CALCIUM TRIHYDRATE
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 71335-3179-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 71335-3179-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

📖 What it is MedlinePlus · NLM

Atorvastatin is used to reduce the risk of heart attack and stroke decrease the amount of cholesterol (a fat-like substance that can build up and clog blood vessels causing heart attacks or strokes or other health problems) Atorvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing how much cholesterol your body makes. This lowers the amount of cholesterol that can build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It lowers LDL cholesterol and triglycerides when used with diet. It also lowers the risk of heart attack and stroke in adults who have CHD or are at higher risk, including people w...
  • Take it by mouth once a day. Any time of day works, and you can take it with or without food. Pick a time you will remember. If you miss a dose, one label says to skip it and take...
  • Common ones include stuffy nose, joint or muscle aches, diarrhea, upset stomach, and trouble sleeping. Many people have few problems. If muscle pain is unexplained or comes with we...
  • Call for unexplained muscle pain, tenderness or weakness, especially with fever. Also call for yellow skin or eyes, or signs of a serious allergy like facial swelling or a blisteri...
📖 Read our full Atorvastatin guide →
2
Nutrient depletion considerations

Atorvastatin Calcium may be associated with lower levels of 2 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Atorvastatin Calcium nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 60 tablets 90 tablets 180 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
71335-3179-01 You're viewing this Main listing 30 TABLET, FILM COATED in 1 BOTTLE 2026-09-08 — Active
71335-3179-02 71335-3179-2 60 TABLET, FILM COATED in 1 BOTTLE 2026-09-08 — Active
71335-3179-03 71335-3179-3 90 TABLET, FILM COATED in 1 BOTTLE 2026-09-08 — Active
71335-3179-04 71335-3179-4 180 TABLET, FILM COATED in 1 BOTTLE 2026-09-08 — Active

You're viewing the smallest of 4 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This is a 30-count package — 30 tablet, film coated in 1 bottle.
How does this package differ from NDC 71335-3179-02?
Both are Atorvastatin Calcium 80 mg Tablet, Film Coated — the drug itself is identical. This page's package is the 30-count one, while NDC 71335-3179-02 is the 60 tablets package.
What NDC number is used to bill for this package of Atorvastatin Calcium 80 mg Tablet, Film Coated?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Atorvastatin Calcium 80 mg 55111-0124-05 Dr. 500 tablets $0.069 AB Availability likely —
Atorvastatin calcium 80 mg 33342-0318-10 Macleods 90 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 42571-0175-10 Micro 1000 tablets $0.069 — Discontinued —
Atorvastatin Calcium 80 mg 50228-0454-05 ScieGen 500 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 00093-5057-05 Teva 500 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 43598-0833-05 Dr. 500 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 72603-0285-01 NorthStar 90 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 00378-3953-05 Mylan 500 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 82009-0179-10 Quallent 1000 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 31722-0427-05 Camber 500 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 51079-0211-03 Mylan 1 tablet $0.069 AB Availability likely —
Atorvastatin calcium 80 mg 72205-0025-05 Novadoz 500 tablets $0.069 AB Availability likely —
atorvastatin calcium 80 mg 70710-1770-00 Zydus 1000 tablets $0.069 AB Availability likely —
Atorvastatin calcium 80 mg 72603-0406-02 NorthStar 100 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 42385-0943-01 Laurus 100 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 70377-0080-11 Biocon 90 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 00480-3588-10 Teva 1000 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 43598-0103-05 Dr. 500 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 67877-0514-05 Ascend 500 tablets $0.069 AB Availability likely —
Atorvastatin Calcium 80 mg 63304-0830-05 Sun 500 tablets $0.072 — FDA listed —
Atorvastatin Calcium 80 mg 69097-0947-05 Cipla 90 tablets $0.079 AB FDA listed —
Atorvastatin Calcium 80 mg 68180-0638-02 Lupin 500 tablets $0.079 — Discontinued —
Atorvastatin Calcium 80 mg 16729-0047-15 Accord 90 tablets $0.079 AB FDA listed —
Lipitor 80 mg 58151-0158-77 Viatris 90 tablets $19.004 AB Availability likely —
Atorvastatin Calcium 80 mg 63187-0907-30 Proficient 30 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 69097-0911-05 Cipla 90 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 71205-0098-30 Proficient 30 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 71610-0036-15 Aphena 15 tablets — AB FDA listed —
Atorvastatin calcium 80 mg 50090-6054-00 A-S 30 tablets — AB FDA listed —
Atorvastatin calcium 80 mg 50090-6970-00 A-S 90 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 71610-0746-15 Aphena 15 tablets — AB FDA listed —
Atorvastatin calcium 80 mg 68071-4962-09 NuCare 90 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 48433-0010-03 Safecor 1 tablet — AB FDA listed —
Atorvastatin Calcium 80 mg 50090-7359-00 A-S 90 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 55154-4384-06 Cardinal 1 tablet — AB FDA listed —
Atorvastatin calcium 80 mg 71205-0335-20 Proficient 20 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 77771-0454-05 Radha 500 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 50090-6061-00 A-S 30 tablets — AB FDA listed —
atorvastatin calcium 80 mg 50090-7725-00 A-S 90 tablets — AB FDA listed —
atorvastatin calcium 80 mg 70771-1878-00 Zydus 1000 tablets — AB FDA listed —
atorvastatin calcium 80 mg 82137-0019-01 Lepu 90 tablets — — FDA listed —
Atorvastatin Calcium 80 mg 50090-7358-00 A-S 30 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 50090-7532-00 A-S 30 tablets — AB FDA listed —
Atorvastatin calcium 80 mg 70518-4473-00 REMEDYREPACK 90 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 72162-1556-09 Bryant 90 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 50090-7533-00 A-S 90 tablets — AB FDA listed —
Atorvastatin calcium 80 mg 70518-3304-00 REMEDYREPACK 30 tablets — AB Discontinued —
Atorvastatin Calcium 80 mg 71209-0093-04 Cadila 90 tablets — — FDA listed —
Atorvastatin Calcium 80 mg 76420-0948-00 Asclemed 1000 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 59651-0609-55 Aurobindo 15000 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 67046-1666-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 68071-2276-09 NuCare 90 tablets — — FDA listed —
Atorvastatin Calcium 80 mg 68071-3874-09 NuCare 90 tablets — AB FDA listed —
Atorvastatin calcium 80 mg 70756-0250-30 Lifestar 30 tablets — AB FDA listed —
Atorvastatin calcium 80 mg 71335-1336-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 71335-2407-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin calcium 80 mg 67046-1593-03 Coupler 30 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 72189-0537-30 Direct_Rx 30 tablets — AB FDA listed —
atorvastatin calcium 80 mg 50090-7724-00 A-S 30 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 63629-8472-01 Bryant 90 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 51655-0747-52 Northwind 30 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 71335-2225-01 Bryant 30 tablets — AB FDA listed —
Atorvastatin Calcium 80 mg 55154-0284-06 Cardinal 1 tablet — AB FDA listed —
Atorvastatin Calcium 80 mgthis 71335-3179-01 Bryant 30 tablets — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Feb 2024
📍
2026
Currently FDA-listed
2 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Atorvastatin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerBryant Ranch Prepack
Application holderAUROBINDO PHARMA LTD
FDA applicationANDA217118 (ANDA)
Labeler code71335
First marketedFeb 2024
Product typeHuman Prescription Drug
Portfolio4,442 products on file

More NDCs from Bryant Ranch Prepack labeler code 71335

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Atorvastatin Calcium — the program that covers self-administered drugs. 26 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Atorvastatin Calcium. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$194.53M
Claims incl. refills
18.7M
Beneficiaries
14.7M
Spend / beneficiary
$13.26
Spend / claim
$10.38
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Bryant Ranch Prepack. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 60 tablets (71335-3179-02), 90 tablets (71335-3179-03), 180 tablets (71335-3179-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Bryant Ranch Prepack is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 71335-3178-01 · Bryant 71335-3180-01 · Bryant →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.